CompletedPHASE2, PHASE3NCT01096082

Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3

Studying Rare genetic neurological disorder

Last synced from ClinicalTrials.gov May 12, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Hospital de Clinicas de Porto Alegre
Principal Investigator: Laura B Jardim, MD PhD, M.D
Medical Genetics Service Hospital de Clinicas de Porto Alegre
Intervention: Lithium Carbonate(drug)
Enrollment: 62 enrolled
Eligibility: 16-80 years · All sexes
Timeline: 2011 – 2013

Study locations (1)

Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01096082 on ClinicalTrials.gov

← Back to all trials